User:FrancoThomas87/sandbox: Difference between revisions
4 new sections added- introduction, history, overview and funding with reference |
added a new section "cyto-mine technology" and added more references to the overall content along with the internal links. |
||
Line 17: | Line 17: | ||
== History == |
== History == |
||
Sphere Fluidics Limited was originally established in 2010, by two chemistry professors of [[Cambridge University]], namely, Professor [[Chris Abell]] and Professor Wilhelm Huck along with Frank F.Craig, an entrepreneur, and Dr.Maher Khaled, a Cambridge University Enterprise.<ref>{{Cite news|url=http://realbusiness.co.uk/tech-and-innovation/2015/03/04/sphere-fluidics-single-cell-analysis-has-never-looked-so-disruptive/|title=Sphere Fluidics: Single cell analysis has never looked so disruptive - Real Business|date=2015-03-04|work=Real Business|access-date=2017-09-13|language=en-US}}</ref> |
Sphere Fluidics Limited was originally established in 2010, by two chemistry professors of [[Cambridge University]], namely, Professor [[Chris Abell]]<ref>{{Cite web|url=http://www.businessweekly.co.uk/news/cambridge-torchbearers/farm-fame-cambridge%E2%80%99s-%E2%80%98cereal%E2%80%99-life-science-entrepreneur|title=From farm to fame, Cambridge’s ‘cereal’ life science entrepreneur {{!}} Business Weekly {{!}} Technology News {{!}} Business news {{!}} Cambridge and the East of England|website=www.businessweekly.co.uk|language=en|access-date=2017-09-13}}</ref> and Professor Wilhelm Huck along with Frank F.Craig, an entrepreneur, and Dr.Maher Khaled, a Cambridge University Enterprise.<ref>{{Cite news|url=http://realbusiness.co.uk/tech-and-innovation/2015/03/04/sphere-fluidics-single-cell-analysis-has-never-looked-so-disruptive/|title=Sphere Fluidics: Single cell analysis has never looked so disruptive - Real Business|date=2015-03-04|work=Real Business|access-date=2017-09-13|language=en-US}}</ref> |
||
In 2013, Sphere Fluidics spun out of Cambridge university to a new research facility in Babraham Research Campus. In 2013, Sphere Fluidics won an award for academic spin-outs at the ACES awards.<ref>{{Cite news|url=https://www.enterprise.cam.ac.uk/news/sphere-fluidics-wins-award-for-academic-spin-outs/|title=Sphere Fluidics wins award for academic spin-outs - Cambridge Enterprise|last=site.|first=Who made this|work=Cambridge Enterprise|access-date=2017-09-13|language=en-GB}}</ref><ref>{{Cite web|url=https://www.labmate-online.com/news/news-and-views/5/university_of_cambridge/sphere_fluidics_wins_award_for_academic_spin-outs/25787|title=Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online|website=www.labmate-online.com|language=en|access-date=2017-09-13}}</ref> |
In 2013, Sphere Fluidics spun out of Cambridge university to a new research facility in Babraham Research Campus. In 2013, Sphere Fluidics won an award for academic spin-outs at the ACES awards.<ref>{{Cite news|url=https://www.enterprise.cam.ac.uk/news/sphere-fluidics-wins-award-for-academic-spin-outs/|title=Sphere Fluidics wins award for academic spin-outs - Cambridge Enterprise|last=site.|first=Who made this|work=Cambridge Enterprise|access-date=2017-09-13|language=en-GB}}</ref><ref>{{Cite web|url=https://www.labmate-online.com/news/news-and-views/5/university_of_cambridge/sphere_fluidics_wins_award_for_academic_spin-outs/25787|title=Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online|website=www.labmate-online.com|language=en|access-date=2017-09-13}}</ref> |
||
Line 24: | Line 24: | ||
In the earlier stages, Sphere Fluidics marketed in the biopharmaceuticals industry, largely. Currently, they operate in anti-microbial screening, synthetic biology, and genome editing of single cells areas, too.<ref name=":0" /> |
In the earlier stages, Sphere Fluidics marketed in the biopharmaceuticals industry, largely. Currently, they operate in anti-microbial screening, synthetic biology, and genome editing of single cells areas, too.<ref name=":0" /> |
||
In 2015, Sphere Fluidics was among the top 20 Intellectual Property League Table Entrants<ref>{{Cite web|url=http://metispartners.com/ip-league-table-2-2/intellectual-property-league-table-2015-results/|title=2015 Results - Autumn Update {{!}} Metis Partners|website=metispartners.com|language=en-US|access-date=2017-09-13}}</ref>. As of 2017, Sphere Fluidics has 36 granted patents and 16 trademarks. |
In 2015, Sphere Fluidics was among the top 20 Intellectual Property League Table Entrants<ref>{{Cite web|url=http://metispartners.com/ip-league-table-2-2/intellectual-property-league-table-2015-results/|title=2015 Results - Autumn Update {{!}} Metis Partners|website=metispartners.com|language=en-US|access-date=2017-09-13}}</ref>. As of 2017, Sphere Fluidics has 36 granted patents and 16 trademarks.<ref>{{Cite web|url=https://www.ipo.gov.uk/p-journal/p-pj/p-pj?lastResult=430&perPage=10&startYear=2015&startMonth=October&startDay=28th+-+6597&endYear=2017&endMonth=May&endDay=17th+-+6678&filter=&sort=Publication+Date&status=undefined|title=Intellectual Property Office - Patents Journal : UK applications filed|last=information@ipo.gov.uk|first=Intellectual Property Office, Concept House, Cardiff Road, Newport, NP10 8QQ.|website=www.ipo.gov.uk|language=English|access-date=2017-09-13}}</ref> |
||
In January 2017, Sphere Fluidics launched an e-commerce platform which had, microfluidic products, research instrument accessories, and microfluidic biochips, on its product line.<ref>{{Cite news|url=https://www.scientifictechnologynews.com/sphere-fluidics-launches-e-commerce-site-allowing-researchers-rapid-access-specialist-microfluidic-products/|title=Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products - Scientific Technology News|date=2017-01-24|work=Scientific Technology News|access-date=2017-09-13|language=en-US}}</ref> |
In January 2017, Sphere Fluidics launched an e-commerce platform which had, microfluidic products, research instrument accessories, and microfluidic biochips, on its product line.<ref>{{Cite news|url=https://biopharmadealmakers.nature.com/users/7626-sphere-fluidics/posts/14600-ssphere-fluidics-launches-e-commerce-site-allowing-researchers-rapid-access-to-specialist-microfluidic-product|title=Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products|last=Dealmakers|first=BioPharma|date=2017-01-24|work=BioPharma Dealmakers|access-date=2017-09-13|language=en-GB}}</ref><ref>{{Cite news|url=https://www.scientifictechnologynews.com/sphere-fluidics-launches-e-commerce-site-allowing-researchers-rapid-access-specialist-microfluidic-products/|title=Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products - Scientific Technology News|date=2017-01-24|work=Scientific Technology News|access-date=2017-09-13|language=en-US}}</ref> |
||
In July 2017, Sphere Fluidics won “Best Investment in Life Sciences” Award, in the event held by UK Business Angels Association.<ref>{{Cite web|url=http://www.businessweekly.co.uk/news/financial/angels-side-cambridge-trio|title=Angels on the side of Cambridge trio {{!}} Business Weekly {{!}} Technology News {{!}} Business news {{!}} Cambridge and the East of England|website=www.businessweekly.co.uk|language=en|access-date=2017-09-13}}</ref><ref>{{Cite news|url=https://www.crowdfundinsider.com/2017/07/119004-uk-angel-investment-awards-powervault-wins-best-angel-crowdfunding-investment-digital-fineprint-wins-best-fintech-investment/|title=UK Angel Investment Awards: Powervault Wins Best Angel Crowdfunding Investment, Digital Fineprint Wins Best Fintech Investment {{!}} Crowdfund Insider|date=2017-07-08|work=Crowdfund Insider|access-date=2017-09-13|language=en-US}}</ref> |
In July 2017, Sphere Fluidics won “Best Investment in Life Sciences” Award, in the event held by UK Business Angels Association.<ref>{{Cite web|url=http://www.businessweekly.co.uk/news/financial/angels-side-cambridge-trio|title=Angels on the side of Cambridge trio {{!}} Business Weekly {{!}} Technology News {{!}} Business news {{!}} Cambridge and the East of England|website=www.businessweekly.co.uk|language=en|access-date=2017-09-13}}</ref><ref>{{Cite news|url=https://www.crowdfundinsider.com/2017/07/119004-uk-angel-investment-awards-powervault-wins-best-angel-crowdfunding-investment-digital-fineprint-wins-best-fintech-investment/|title=UK Angel Investment Awards: Powervault Wins Best Angel Crowdfunding Investment, Digital Fineprint Wins Best Fintech Investment {{!}} Crowdfund Insider|date=2017-07-08|work=Crowdfund Insider|access-date=2017-09-13|language=en-US}}</ref> |
||
Line 33: | Line 33: | ||
== Funding == |
== Funding == |
||
Sphere Fluidics has raised £11 million as of 2017, from investors namely, 24 Haymarket |
Sphere Fluidics has raised £11 million as of 2017, from investors namely, 24 Haymarket<ref>{{Cite web|url=http://www.globaluniversityventuring.com/article.php/3633/investment-flows-towards-sphere-fluidics|title=Investment flows towards Sphere Fluidics · Articles · Global University Venturing|website=www.globaluniversityventuring.com|access-date=2017-09-13}}</ref>, [[Amadeus Capital Partners]], Greenwood Way Capital, University of Cambridge Enterprise, University of Cambridge, Parkwalk Advisors, Providence Investment Company, London Business Angels<ref>{{Cite news|url=http://www.bmmagazine.co.uk/get-funded/success-stories/london-business-angels-investment-helps-sphere-fluidics-close-1-6m-early-stage-funding-round/|title=London Business Angels investment helps Sphere Fluidics close £1.6m early stage funding round|date=2013-03-10|work=Business Matters|access-date=2017-09-13|language=en-GB}}</ref>, Envestors, Angels5K, [[Cambridge Angels]], Q-Ventures and a Japanese corporate investor.<ref name=":1">{{Cite web|url=https://www.gov.uk/government/news/sphere-fluidics-biotherapeutics-device-attracts-7m-investment|title=Sphere Fluidics: biotherapeutics device attracts $7m investment - GOV.UK|website=www.gov.uk|language=en|access-date=2017-09-13}}</ref><ref>{{Cite web|url=https://www.cambridgenetwork.co.uk/news/sphere-fluidics-closes-a-1pt6m-series-a-investment-round/|title=Sphere Fluidics successfully closes a £1.6 million Series A investment round|website=Cambridge Network|language=en|access-date=2017-09-13}}</ref> |
||
== Cyto-Mine Technology == |
|||
Cyto-Mine Technology is one of the [[Patent|patented]] products of Sphere Fluidics.<ref>{{Cite web|url=http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=433708|title=Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"! {{!}} Evaluate|website=www.evaluategroup.com|access-date=2017-09-13}}</ref> |
|||
Cyto-Mine technology is the integrated device that is able to automatically perform [[Single-cell analysis|single cell analysis]], sorting, imaging and dispensing into individual wells of microtitre plates in a single compact system.<ref name=":1" /> Based on the research made by Professors Chris Abell and Wilhelm Huck, this biochip system can automatically process millions to billions of miniaturised tests in tiny picodroplets.<ref>{{Cite news|url=https://www.enterprise.cam.ac.uk/news/sphere-fluidics-wins-7-million-for-development-of-single-cell-analysis-system/|title=Sphere Fluidics wins $7 million for development of single cell analysis system - Cambridge Enterprise|last=site.|first=Who made this|work=Cambridge Enterprise|access-date=2017-09-13|language=en-GB}}</ref> |
|||
According to the scientists of Sphere Fluidics, Cyto-Mine can perform millions of single-cell assays daily, offering up to a 100-fold improvement over conventional techniques, at lower capital and operational cost. <ref name=":1" /> |
|||
== References == |
== References == |
Revision as of 07:56, 13 September 2017
Founded | February 24, 2010 |
---|---|
Founders | Professor Chris Abell, Frank. F.Craig, Professor Wilhelm Huck, and Dr.Maher Khaled |
Type | Private |
Headquarters | Babraham, United Kingdom |
Services | anti-microbial screening, synthetic biology, and genome editing of single cells. |
Website | spherefluidics |
Sphere Fluidics Limited
Sphere Fluidics is an England-based Life Sciences Research and Development company specializing in biopharmaceutical discovery and development, cell therapy engineering, analysis and isolation.[1] Sphere Fluidics has been named one of the UK's top 50 disruptive SMEs by Real Business in 2015.[2]
History
Sphere Fluidics Limited was originally established in 2010, by two chemistry professors of Cambridge University, namely, Professor Chris Abell[3] and Professor Wilhelm Huck along with Frank F.Craig, an entrepreneur, and Dr.Maher Khaled, a Cambridge University Enterprise.[4]
In 2013, Sphere Fluidics spun out of Cambridge university to a new research facility in Babraham Research Campus. In 2013, Sphere Fluidics won an award for academic spin-outs at the ACES awards.[5][6]
Overview
In the earlier stages, Sphere Fluidics marketed in the biopharmaceuticals industry, largely. Currently, they operate in anti-microbial screening, synthetic biology, and genome editing of single cells areas, too.[1]
In 2015, Sphere Fluidics was among the top 20 Intellectual Property League Table Entrants[7]. As of 2017, Sphere Fluidics has 36 granted patents and 16 trademarks.[8]
In January 2017, Sphere Fluidics launched an e-commerce platform which had, microfluidic products, research instrument accessories, and microfluidic biochips, on its product line.[9][10]
In July 2017, Sphere Fluidics won “Best Investment in Life Sciences” Award, in the event held by UK Business Angels Association.[11][12]
In August 2017, a new lab and facility from Sphere Fluidics was opened in Monmouth Junction, New Jersey.
Funding
Sphere Fluidics has raised £11 million as of 2017, from investors namely, 24 Haymarket[13], Amadeus Capital Partners, Greenwood Way Capital, University of Cambridge Enterprise, University of Cambridge, Parkwalk Advisors, Providence Investment Company, London Business Angels[14], Envestors, Angels5K, Cambridge Angels, Q-Ventures and a Japanese corporate investor.[15][16]
Cyto-Mine Technology
Cyto-Mine Technology is one of the patented products of Sphere Fluidics.[17]
Cyto-Mine technology is the integrated device that is able to automatically perform single cell analysis, sorting, imaging and dispensing into individual wells of microtitre plates in a single compact system.[15] Based on the research made by Professors Chris Abell and Wilhelm Huck, this biochip system can automatically process millions to billions of miniaturised tests in tiny picodroplets.[18]
According to the scientists of Sphere Fluidics, Cyto-Mine can perform millions of single-cell assays daily, offering up to a 100-fold improvement over conventional techniques, at lower capital and operational cost. [15]
References
- ^ a b "Sphere Fluidics Raises $7 Million for Development Of Cyto-Mine Single Cell Analysis System - SynBioBeta". synbiobeta.com. Retrieved 2017-09-13.
- ^ site., Who made this. "Sphere Fluidics named one of Britain's most disruptive businesses - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.
- ^ "From farm to fame, Cambridge's 'cereal' life science entrepreneur | Business Weekly | Technology News | Business news | Cambridge and the East of England". www.businessweekly.co.uk. Retrieved 2017-09-13.
- ^ "Sphere Fluidics: Single cell analysis has never looked so disruptive - Real Business". Real Business. 2015-03-04. Retrieved 2017-09-13.
- ^ site., Who made this. "Sphere Fluidics wins award for academic spin-outs - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.
- ^ "Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online". www.labmate-online.com. Retrieved 2017-09-13.
- ^ "2015 Results - Autumn Update | Metis Partners". metispartners.com. Retrieved 2017-09-13.
- ^ information@ipo.gov.uk, Intellectual Property Office, Concept House, Cardiff Road, Newport, NP10 8QQ. "Intellectual Property Office - Patents Journal : UK applications filed". www.ipo.gov.uk. Retrieved 2017-09-13.
{{cite web}}
: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link) - ^ Dealmakers, BioPharma (2017-01-24). "Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products". BioPharma Dealmakers. Retrieved 2017-09-13.
- ^ "Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products - Scientific Technology News". Scientific Technology News. 2017-01-24. Retrieved 2017-09-13.
- ^ "Angels on the side of Cambridge trio | Business Weekly | Technology News | Business news | Cambridge and the East of England". www.businessweekly.co.uk. Retrieved 2017-09-13.
- ^ "UK Angel Investment Awards: Powervault Wins Best Angel Crowdfunding Investment, Digital Fineprint Wins Best Fintech Investment | Crowdfund Insider". Crowdfund Insider. 2017-07-08. Retrieved 2017-09-13.
{{cite news}}
: no-break space character in|title=
at position 129 (help) - ^ "Investment flows towards Sphere Fluidics · Articles · Global University Venturing". www.globaluniversityventuring.com. Retrieved 2017-09-13.
- ^ "London Business Angels investment helps Sphere Fluidics close £1.6m early stage funding round". Business Matters. 2013-03-10. Retrieved 2017-09-13.
- ^ a b c "Sphere Fluidics: biotherapeutics device attracts $7m investment - GOV.UK". www.gov.uk. Retrieved 2017-09-13.
- ^ "Sphere Fluidics successfully closes a £1.6 million Series A investment round". Cambridge Network. Retrieved 2017-09-13.
- ^ "Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"! | Evaluate". www.evaluategroup.com. Retrieved 2017-09-13.
- ^ site., Who made this. "Sphere Fluidics wins $7 million for development of single cell analysis system - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.